The Annual General Meeting of Shareholders of BioPorto A/S will be held on Wednesday, April 20, 2010, at 3:00 p.m. at the Company's address, Grusbakken 8, DK-2820 Gen-tofte, Denmark With the following agenda: 1. Report on the Company's activities during the past financial year; 2. Presentation of the Annual Report for 2009 with annual accounts endorsed by Management and Auditor, including proposal for the use of profit or coverage of deficit and grant of dis-charge for the Management, for approval; 3. Election of board members and possibly deputy members; The Board of Directors proposes the re-election of the full Board; Carsten Lønfeldt, Peter Nordkild, Niels T. Foged and Marianne Weile. 4. Election of Auditor and possibly of a deputy Auditor; The Board of Directors proposes the re-election of Deloitte; 5. Proposals from the Board of Directors, for approval: Amendments to the Company Articles; As a consequence of the new Danish Companies Act the new concepts of the Act shall be incorporated in the Company Articles. The Board proposes that the opportunity is also used to modernize the Articles. The changes that are required under the new Companies Act are made together under agenda item 5.a. Under agenda item 5.b. a series of proposals for con-sequential amendments and other Article changes of policy-related or procedural nature are made. Finally, under agenda item 5.c - 5.e other proposals for Article changes are made. a. Changes required under the new Companies Act; b. Consequential changes and amendments of policy-related or procedural nature; c. Deleting "Realinvest.dk A / S" as a secondary name (§ 1). d. Adding terms for electronic communications; The Board proposes that the Articles added a new provision (§ 11) providing for the possible use of electronic communication between company and shareholders. e. Modification of authorization to issue warrants (§ 15d); The Board proposes that the authorization to issue warrants in Articles § 15d is clarified so that the Board within the authorization limits has the right to reissue or reuse warrants. 6. Any other business. A detailed text of the proposals is available only in Danish. Please contact the Company for further information. Share capital, voting rights and authorized institution The current share capital of the Company amounts to DKK 126,397,872. The share capital is fully paid up and divided into shares of nominal value DKK 3.00 (42,132,624 shares). Each share gives one vote (42,132,624 votes). Adoption of the proposals under the agenda item 5 requires approval by at least two thirds of the votes cast and two thirds of the General Meeting voting share capital represented. Under the rules of corporate law, the proposals under item 5.a can be adopted if only one shareholder votes in favor of the proposals. The adoption of the other proposals requires a simple majority. Admission card and proxy Admission to the Annual General Meeting is conditional on the presentation of an admission card, which can be obtained by written request to the BioPorto office no later than April 15, 2010, 4:00 p.m. The form is sent to the shareholders who have so requested, and is available on the company website www.bioporto.com. Shareholders may submit a proxy to the Board or a person designated by the shareholder who par-ticipates in the meeting. Admission card and proxy form can be obtained on the company website or by written request to the BioPorto office. Completed proxy forms must be received by the company no later than April 15, 2010, 4:00 p.m. Admission cards to shareholder's advisers or administrators must also be resolved within the period specified Submission of documents and questions The summoning with agenda, complete proposals, information on voting rights and share capital as well as documents presented at the meeting, including the audited annual report will be available on the company website www.bioporto.com in the period from 3 weeks before the meeting through the date of the meeting. In the same period, the documents will be presented for inspection by the share-holders at the company office, Grusbakken 8, DK-2820 Gentofte, all weekdays from 10:00 a.m. to 16:00 p.m. Until the day before the General Meeting, shareholders may address questions regarding the agenda or documents to the company in writing. BioPorto A/S The Board of Directors Further information: Christina Tønnesen, Investor Relations Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com